{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:46:13Z","timestamp":1791812773671,"version":"4.3.4"},"reference-count":35,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Asparaginase is a critical treatment component for patients with acute lymphoblastic leukemia\/lymphoblastic lymphoma (ALL\/LBL). However, the successful delivery of asparaginase\u2010based therapy remains challenging across care settings due to its complex administration, distinct toxicity profile, prolonged treatment duration, and the need for coordinated multidisciplinary care. These challenges are further compounded by variability in institutional infrastructure, provider experience, and access to specialized supportive services. In this article, we describe key operational and clinical barriers to the safe, timely, and complete delivery of asparaginase therapy for patients with ALL\/LBL and present recommendations developed using a modified Delphi process incorporating literature review and expert consensus. We provide practical recommendations organized across three core areas: (1) defining essential members of the specialized care team and outlining the necessary infrastructure for safe and effective asparaginase administration; (2) identifying key steps in the asparaginase treatment journey for ALL\/LBL patients and providing recommendations for successful patient navigation and improved outcomes; and (3) sharing practical resources and solutions used by pharmacists, advanced practice providers, and nurses to optimize asparaginase delivery and ensure treatment completion. These recommendations are intended to provide actionable guidance to harmonize multidisciplinary efforts, minimize avoidable treatment interruptions, and support completion of planned asparaginase therapy. Broad implementation across specialized and nonspecialized centers may improve treatment adherence, mitigate toxicity\u2010related discontinuation, and ultimately optimize outcomes for patients with ALL\/LBL receiving asparaginase.<\/jats:p>","DOI":"10.1002\/ajh.70458","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T02:25:25Z","timestamp":1786760725000},"page":"2713-2725","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Navigating Asparaginase Treatment for Patients With Acute Lymphoblastic Leukemia:\n                    <scp>US<\/scp>\n                    Consensus Panel Recommendations on the Role of Multidisciplinary Care"],"prefix":"10.1002","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2584-5427","authenticated-orcid":false,"given":"Amir","family":"Ali","sequence":"first","affiliation":[{"name":"University of Southern California Norris Cancer Hospital  Los Angeles California USA"},{"name":"University of Southern California Mann School of Pharmacy  Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Elsey","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Atrium Health, Levine Cancer  Charlotte North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Fulginiti","sequence":"additional","affiliation":[{"name":"Elephants and Tea  Avon Lake Ohio USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8847-9389","authenticated-orcid":false,"given":"Zanette","family":"Kanani\u2010Bradley","sequence":"additional","affiliation":[{"name":"Children's Hospital Colorado  Aurora Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2070-6683","authenticated-orcid":false,"given":"Holly R.","family":"Kubaney","sequence":"additional","affiliation":[{"name":"Children's Blood and Cancer Center, Dell Children's Medical Center  Austin Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Kurtin","sequence":"additional","affiliation":[{"name":"The University of Arizona Cancer Center  Tuscon Arizona USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Dana\u2010Farber Cancer Institute  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Turchina","sequence":"additional","affiliation":[{"name":"University of Cincinnati Medical Center  Cincinnati Ohio USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0568-0781","authenticated-orcid":false,"given":"Charlotte B.","family":"Wagner","sequence":"additional","affiliation":[{"name":"University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences  Aurora Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon\u20102021\u20101288"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2022.08.009"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.5305"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2021.100908"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1089\/jayao.2015.0014"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.2147\/BLCTT.S342052"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102018\u201010\u2010881961"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.229"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26066"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.265"},{"key":"e_1_2_12_12_1","article-title":"Long\u2010Term Follow\u2010Up of an Intensive Pediatric Regimen for Adolescents\/Young Adults (AYA) With Acute Lymphoblastic Leukemia (ALL): 10\u2010Year Survival Following CALGB 10403 (ALLIANCE)","volume":"9","author":"Stock W.","year":"2025","journal-title":"HemaSphere"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375\u2010023\u201002115\u20104"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277\u2010025\u201006682\u20107"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023023568"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006469"},{"key":"e_1_2_12_17_1","unstructured":"National Comprehensive Cancer Network Inc \u201cReferenced With Permission From the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Acute Lymphoblastic Leukemia V.1.2026\u201d(National Comprehensive Cancer Network Inc. 2026) All Rights Reserved accessed May 2 2026 to View the Most Recent and Complete Version of the Guideline Go Online to NCCN.org. NCCN Makes No Warranties of Any Kind Whatsoever Regarding Their Content Use or Application and Disclaims Any Responsibility for Their Application or Use in Any Way."},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.70103"},{"key":"e_1_2_12_19_1","volume-title":"The Children's Oncology Group Family Handbook","author":"Children's Oncology Group","year":"2011"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.7097"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/op.23.00373"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol31090406"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055\u20109965.Epi\u201016\u20100722"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27074"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055\u20109965.Epi\u201018\u20100430"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation\u20102018.1.154"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.902117"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899\u2010020\u201000597\u2010y"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/op.21.00178"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25229"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102014\u201011\u2010551481"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136\u2010009\u20109496\u20109"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation\u20102018.1.146"},{"key":"e_1_2_12_34_1","unstructured":"Children's Oncology Group.\u201cLong\u2010Term Follow\u2010Up Guidelines for Survivors of Childhood Adolescent and Young Adult Cancers. Version 6.0. Children's Oncology Group; October 2023\u201d https:\/\/childrensoncologygroup.org\/wp\u2010content\/uploads\/2026\/05\/COG_LTFU_Guidelines_Comprehensive_v6.pdf."},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/op\u201025\u201000748"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1712533"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.70458","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ajh.70458","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.70458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:56:28Z","timestamp":1791809788000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.70458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1002\/ajh.70458"],"URL":"https:\/\/doi.org\/10.1002\/ajh.70458","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"2026-05-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}